Meningitis B vaccine scheme widened to include some year 11 pupils in Kent

Scheme expanded to four schools with known or suspected cases, as UKHSA figures show number has fallen to 23

The meningitis B vaccination programme will be expanded to include year 11 pupils at schools affected by the outbreak in Kent, health officials have said.

Figures from the UK Health Security Agency (UKHSA) show the number of cases of the illness have fallen.

Continue reading...

Meningitis vaccine eligibility expanded after Kent outbreak rises to 27

Anyone who was at Club Chemistry in Canterbury from 5 March to 15 March advised to get antibiotics and vaccination

The government has announced a major expansion in vaccination against meningitis in Kent after seven new cases of the disease were confirmed in the county, taking the total number of cases to 27.

On a visit to the University of Kent, the health secretary, Wes Streeting, said anyone who attended the Club Chemistry nightclub in Canterbury from 5 March until 15 March should come forward for antibiotics and vaccination.

Continue reading...

Bacteria that cause meningitis on the rise, CDC warns

US public health agency alert warns of 422 cases reported in the country last year, the highest number since 2014

An invasive meningococcal disease – which can be deadly to infected people – is on the rise, the US Centers for Disease Control and Prevention (CDC) warned.

In an alert issued on Thursday, the CDC warned that there were 422 cases of the disease reported in the US last year, the highest annual number of cases reported since 2014.

Continue reading...

‘A gamechanger’: new meningitis vaccine hailed as major step

Successful trials in Africa of NmCV-5 vaccine open the door to affordable treatment for disease that kills 250,000 people a year

An effective, affordable meningitis vaccine has been successfully tested in Africa, raising hopes for the elimination of a disease that kills 250,000 people a year.

The NmCV-5 vaccine, developed by the Serum Institute of India and global health organisation Path, will protect against the five main meningococcal strains found in Africa, including the emerging X strain, for which there is currently no licensed injection.

Continue reading...